Ticker Details
Tourmaline Bio, Inc. Common Stock
IPO Date:	May 3, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$775.39M
Activated in VL:	False

Average Daily Range
Avg Daily Range:	$0.68 | 3.27%
Avg Daily Range (30 D):	$0.60 | 2.64%
Avg Daily Range (90 D):	$0.53 | 2.81%

Institutional Daily Volume
Avg Daily Volume:	.22M
Avg Daily Volume (30 D):	.2M
Avg Daily Volume (90 D):	.21M

Trade Size
Avg Trade Size (Sh.):	60
Avg Trade Size (Sh.) (30 D):	51
Avg Trade Size (Sh.) (90 D):	53

Institutional Trades
Total Institutional Trades:	315
Avg Institutional Trade:	$2.3M
Avg Institutional Trade (30 D):	$4.19M
Avg Institutional Trade (90 D):	$3.79M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$1.84M
Avg Closing Trade (30 D):	$.67M
Avg Closing Trade (90 D):	$.97M
Avg Closing Volume:	96.59K

News

Oct 16, 2025 @ 5:00 PM Thyroid Eye Disease Clinical Trial Pipeline Gains ... Source: Delveinsight

Oct 8, 2025 @ 9:51 PM $HAREHOLDER ALERT: The M&A Class Action Continues ... Source: Juan Monteverde

Sep 26, 2025 @ 5:15 AM Novartis to showcase transformative data in advanc... Source: Novartis

Sep 15, 2025 @ 9:30 PM SHAREHOLDER ALERT: The M&A Class Action Firm Annou... Source: Juan Monteverde

Sep 9, 2025 @ 12:10 PM Novartis To Expand Heart Drug Portfolio With $1.4 ... Source: Vandana Singh

Financials
	TTM	Q1 2025	Q3 2024
Basic EPS		$-.89	$-.78
Diluted EPS		$-.89	$-.78
Revenue		$M	$M
Gross Profit
Net Income / Loss		$-22.97M	$-20.18M
Operating Income / Loss		$-26.23M	$-24.44M
Cost of Revenue
Net Cash Flow		$4.82M	$-35.14M
PE Ratio